Evidence map›Paper›PMID 41876837›Full record

ArticleScientific reports2026

Insights into the antibacterial mode of action of cress polysaccharide-mediated NiO nanoparticles.

Yusra Jamil, Mansoor Ali, Sajid Ali, Douglas Law, Abdulwahed Fahad Alrefaei, Ayaz Ahmad

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yusra JamilDepartment of Biotechnology, Abdul Wali Khan University Mardan, Mardan, 23200, Khyber Pakhtunkhwa, Pakistan.
Mansoor AliDepartment of Biotechnology, Abdul Wali Khan University Mardan, Mardan, 23200, Khyber Pakhtunkhwa, Pakistan.
Sajid AliDepartment of Horticulture and Life Science, Yeungnam University, Gyeongsan, 38541, Republic of Korea. drsajid@yu.ac.kr.
Douglas LawFaculty of Health and Life Sciences, INTI International University, Nilai, 71800, Negeri Sembilan, Malaysia.
Abdulwahed Fahad AlrefaeiDepartment of Zoology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Ayaz AhmadDepartment of Biotechnology, Abdul Wali Khan University Mardan, Mardan, 23200, Khyber Pakhtunkhwa, Pakistan. ahdayazb5@awkum.edu.pk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of antimicrobial resistance necessitates the development of alternative antibacterial strategies. In this study, nickel oxide nanoparticles (NiO NPs) were synthesized using cress (Lepidium sativum) seed mucilage polysaccharides (CSP) as a green reducing and stabilizing agent. The formation of CSP-mediated NiO nanoparticles (CSP-NiO) was confirmed through extensive characterization using UV-Visible, FTIR, XRD, SEM, and EDX techniques. The CSP-NiO NPs exhibited minimal erythrocyte toxicity (< 5% hemolysis at 200 µg/mL) and dose-dependent antibacterial activity against Gram-positive (Staphylococcus aureus and Clostridium tetani) and Gram-negative (Escherichia coli and Klebsiella pneumoniae) bacteria, with MIC values ranging from 25 to 50 µg/mL. The mechanistic investigations revealed increased intracellular reactive oxygen species (ROS) production, membrane disruption (evidenced by protein leakage), and genomic DNA damage in treated bacterial cells. These findings suggest that CSP-NiO NPs exert antibacterial effects through oxidative stress, leading to membrane disruption and genomic DNA damage, thereby establishing them as a sustainable nanomaterial platform for future antimicrobial applications.

Indexed as

Anti-Bacterial AgentsMetal NanoparticlesNickelPolysaccharidesDNA DamageEscherichia coliMicrobial Sensitivity TestsReactive Oxygen SpeciesAnti-Bacterial AgentsNickelnickel monoxidePolysaccharidesReactive Oxygen SpeciesAntibacterial mechanismAntibiotic resistanceBiocompatibilityGreen synthesisHuman healthNiO nanoparticlesPolysaccharidesROS

Identifiers

PMID41876837
PMCPMC13168473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.